Histological and genetic changes in malignant transformation of gallbladder adenoma

Citation
H. Watanabe et al., Histological and genetic changes in malignant transformation of gallbladder adenoma, ANN ONCOL, 10, 1999, pp. 136-139
Citations number
22
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
ANNALS OF ONCOLOGY
ISSN journal
09237534 → ACNP
Volume
10
Year of publication
1999
Supplement
4
Pages
136 - 139
Database
ISI
SICI code
0923-7534(1999)10:<136:HAGCIM>2.0.ZU;2-L
Abstract
Design: Elucidate the histological and genetic changes in malignant transfo rmation of adenoma of the gallbladder. Materials and methods: Forty-three adenomas and 20 intramucosal tumors of c arcinoma-in-adenomas were studied for histological and genetic changes (par ticularly K-ras mutation and p53 protein overexpression by immunohistochemi stry) in malignant transformation. The genetic changes were compared with t hose of 164 carcinomas without anomalous union and 17 carcinomas with anoma lous union of pancreatico-biliary duct. Results: Atypical cell foci, i.e. spindle cell foci, were observed only in the adenoma area, with a frequency of 23% in 39 adenomas, and of 45% in 20 tumors of carcinoma-in-adenoma. 129 of 130 spindle cell foci examined were negative for Ki-67 staining and all the spindle cell foci were negative for p53 slain. K-ras mutation and p53 overexpression were not found in all ade nomas, pure and with carcinoma i.s., and only one carcinoma (1/16, 6%) with adenoma showed p53 overexpression. K-ras mutation was low (10%, 4/40) in c arcinomas without adenoma, but high in carcinomas with anomalous union of p ancreatico-biliary duct. While, p53 overexpression was high and similar in carcinomas with and without anomalous union. Conclusions: These results suggest that there an three distinct pathways in gallbladder carcinogenesis; that is, de novo carcinoma develops from a pre dominant p53 alteration with low K-ras mutation, de novo carcinoma with ano malous union from K-ras mutation and p53 mutation, and carcinoma-in-adenoma from K-ras-, p53-, and probably APC-gene-related, as yet unknown, alterati on.